文献速递脑血管病

PREVENT方程:对卒中预防的启示

PREVENT Equations: Implications for Stroke Prevention.
PubMed 文献 · Stroke · 2026-07-08

本综述强调有效卒中预防需转向全局心血管风险评估,并介绍美国心脏协会开发的PREVENT方程。该方程采用性别特异性、无种族公式,纳入肾功能、竞争性非心血管死亡,可选纳入社区剥夺,外部验证显示校准优于汇总队列方程,有助于更可靠地估计绝对治疗获益。

要点

  • 卒中预防应基于整体心血管风险而非孤立卒中风险。
  • PREVENT方程纳入肾功能和竞争性死亡,校准优于汇总队列方程。
  • PREVENT适用于首次事件前风险因素优化决策,含10年、30年和风险年龄输出。

核心结论

  • 有效卒中预防需要转向全局心血管风险评估,PREVENT方程可支持更可靠的绝对治疗获益估计。

研究设计与样本

  • 本综述旨在强调卒中预防需转向全局心血管风险评估,并突出新型风险预测工具的临床效用。

主要发现

  • PREVENT方程由美国心脏协会开发,使用性别特异性、无种族公式建模整体心血管疾病风险。
  • 该方程纳入肾功能、考虑竞争性非心血管死亡,并可选纳入社区剥夺。
  • 外部验证提示PREVENT方程校准优于汇总队列方程。

关键数值与推荐

  • PREVENT方程提供10年、30年和风险年龄输出,用于血压、降脂治疗和心血管-肾脏-代谢管理决策。
  • PREVENT方程未纳入心房颤动等主要非动脉粥样硬化性卒中驱动因素。

临床怎么用

  • 临床医生可将PREVENT用于首次事件前风险因素优化决策,包括血压、降脂治疗和患者沟通。
  • PREVENT方程在电子健康记录工作流中实施、自动填充输入和风险关联治疗路径可影响其临床影响和公平性。

局限性

  • PREVENT方程聚焦整体而非病因特异性心血管风险,缺乏卒中机制特异性估计。
  • PREVENT方程未纳入心房颤动等主要非动脉粥样硬化性卒中驱动因素。
  • PREVENT方程缺乏影像分层治疗效应估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke remains a leading cause of death and long-term disability. Yet, much of its burden is preventable through earlier and more intensive management of vascular and cardiovascular-kidney-metabolic risk factors. Primary prevention is challenging as the first clinical event is often unpredictable and may manifest as stroke, myocardial infarction, heart failure, or peripheral arterial disease. Contemporary tools, therefore, estimate overall cardiovascular risk rather than stroke risk in isolation. The goal of this review is to emphasize that effective stroke prevention requires a shift toward global cardiovascular risk assessment and to highlight the potential clinical utility of newer risk prediction tools. The predicting risk of cardiovascular disease events equations, developed by the American Heart Association, update absolute risk estimation by modeling overall cardiovascular disease risk using sex-specific, race-free equations that incorporate kidney function, account for competing noncardiovascular death, and optionally include neighborhood deprivation. External validations suggest improved calibration compared with pooled cohort equations, supporting a more reliable estimation of absolute treatment benefit. For clinicians managing patients at risk for stroke, predicting risk of cardiovascular disease events is most useful when the clinical question is how aggressively to optimize risk factors before the first event, including decisions about blood pressure, lipid-lowering therapy, cardiovascular-kidney-metabolic management, and patient communication using 10-year, 30-year, and risk age outputs. Key limitations include its focus on overall rather than cause-specific cardiovascular risk, lack of stroke mechanism-specific estimates, absence of major nonatherosclerotic stroke drivers such as atrial fibrillation, and lack of imaging-stratified treatment-effect estimates. Predicting the risk of cardiovascular disease events' ultimate clinical impact and equity will depend on implementation within electronic health record workflows, autopopulated inputs, treatment pathways tied to estimated risk, and complementary cause-specific evaluation when clinically indicated.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ahmed T, Mathew RO, Elkind MSV, et al. PREVENT Equations: Implications for Stroke Prevention. Stroke. 2026. PMID: 42417034. doi:10.1161/STROKEAHA.126.053362

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。